Don’t miss the latest developments in business and finance.

Aventis Pharma launches SoloStar in India

Image
BS Reporter Ahmedabad
Last Updated : Jan 20 2013 | 9:08 PM IST

"The insulin market in India is about Rs 410 crore and we have captured a market of about 7% with Lantus. The launch of SoloStar will boost our market share by another 1-2%," said Susheel Umesh, senior director, Cardio-Metabolism Business Unit who was in Ahmedabad for the launch. The Chicago Athenaeum Museum of Architecture and Design awarded the 2007 Good Design award to SoloStar.

Lantus has a global market of 2 billion Euros. SoloStar reduces the injection force by 30% or more in comparison to other leading disposable pens, he added.

According to diabetologist Sanjeev Phatak after Tamil Nadu, Gujarat has highest prevalence of diabetes. "There would be 30-40 lakh diabetes patients in Gujarat of which about 4-5 lakh would be in Ahmedabad," Phatak said.

Also Read

First Published: May 13 2008 | 6:13 PM IST

Next Story